logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (viii) All inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates27.055.969.767.060.059.249.331.2115081075
Cocaine2.34.36.29.110.110.06.51.41080140
Stimulants19.319.511.99.99.76.97.44.13271210
Hypnotics and sedatives3.52.63.65.711.615.828.152.21009261
Hallucinogens0.30.20.10.00.10.00.00.0367
Volatile substances5.01.40.50.30.00.90.50.331410
Cannabis 39.214.16.86.96.54.94.62.43000301
Other substances 3.32.01.21.12.02.23.78.5417259
Total2910936846541908834449217295206352263

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LV, LU,HU, AT, RO, SK, FI, SE, HR, TR. 

 Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010